These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8744282)

  • 41. New highly sensitive sandwich ELISA system for soluble endoglin quantification in different biological fluids.
    Smirnov IV; Gryazeva IV; Vasileva MY; Krutetskaia IY; Shashkova OA; Samoylovich MP; Stolbovaya AY; Solodovnikova NG; Zazerskaya IE; Sokolov DI; Selkov SA; Klimovich VB
    Scand J Clin Lab Invest; 2018 Oct; 78(6):515-523. PubMed ID: 30270756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies to factor XII associated with lupus anticoagulant.
    Jones DW; Gallimore MJ; Harris SL; Winter M
    Thromb Haemost; 1999 Mar; 81(3):387-90. PubMed ID: 10102466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3.
    Garred P; Mollnes TE; Lea T
    Scand J Immunol; 1988 Mar; 27(3):329-35. PubMed ID: 2451274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies to factor XII are distinct from antibodies to prothrombin in patients with the anti-phospholipid syndrome.
    Jone DW; Nicholls PJ; Donohoe S; Gallimore MJ; Winter M
    Thromb Haemost; 2002 Mar; 87(3):426-30. PubMed ID: 11916074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.
    Bertolaccini ML; Mepani K; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2007 Apr; 66(4):533-6. PubMed ID: 17020907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A quantitative dot immunobinding assay for coagulation factor XII in plasma.
    Wuillemin WA; Furlan M; Lämmle B
    J Immunol Methods; 1990 Jun; 130(1):133-40. PubMed ID: 2358685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).
    Morrison DC; Cochrane CG
    J Exp Med; 1974 Sep; 140(3):797-811. PubMed ID: 4378413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that two of 49 subjects are cross-reacting material positive (CRM+).
    Saito H; Scott JG; Movat HZ; Scialla SJ
    J Lab Clin Med; 1979 Aug; 94(2):256-65. PubMed ID: 110893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathways of kinin formation and role in allergic diseases.
    Kaplan AP; Silverberg M; Ghebrehiwet B; Atkins P; Zweiman B
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S41-51. PubMed ID: 2910589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative assay of the Hageman factor.
    Hunter DT; Allensworth JL
    Am J Clin Pathol; 1967 Apr; 47(4):448-53. PubMed ID: 6021547
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of a highly sensitive and specific monoclonal antibody-based enzyme-linked immunosorbent assay (ELISA) for detection of Sudan I in food samples.
    Wang Y; Wei D; Yang H; Yang Y; Xing W; Li Y; Deng A
    Talanta; 2009 Mar; 77(5):1783-9. PubMed ID: 19159799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Factor XII (Hageman factor)].
    Saito H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():657-9. PubMed ID: 15658416
    [No Abstract]   [Full Text] [Related]  

  • 55. A monoclonal antibody recognizing an iscosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation.
    Pixley RA; Colman RW
    Adv Exp Med Biol; 1989; 247A():473-6. PubMed ID: 2481390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibodies against human angiotensinogen, their characterization and use in an angiotensinogen enzyme linked immunosorbent assay.
    Rubin I; Lykkegaard S; Olsen AA; Selmer J; Ballegaard M
    J Immunoassay; 1988; 9(3-4):257-74. PubMed ID: 2466873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor).
    Ogston D; Bennett NB; Ogston CM; Ratnoff OD
    Br J Haematol; 1971 Feb; 20(2):209-16. PubMed ID: 5548486
    [No Abstract]   [Full Text] [Related]  

  • 58. Hageman factor deficiency presentation and implications for management.
    Harper K; Friedland ML
    Conn Med; 1992 Sep; 56(9):469-71. PubMed ID: 1424610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hageman factor (factor XII) deficiency in marine mammals.
    Robinson AJ; Kropatkin M; Aggeler PM
    Science; 1969 Dec; 166(3911):1420-2. PubMed ID: 5388978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Normal range and genetic analysis of coagulation factor XII in the general Chinese population.
    Han Y; Zhu T; Jiao L; Hua B; Cai H; Zhao Y
    Thromb Res; 2015 Aug; 136(2):440-4. PubMed ID: 26105808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.